• The Promise of Lung Cancer Precision Medicine with Dr. Jonathan Spicer

  • Feb 12 2024
  • Length: 26 mins
  • Podcast

The Promise of Lung Cancer Precision Medicine with Dr. Jonathan Spicer

Listen for free

View show details

  • Summary

  • Episode Highlights
    0:15 Intro
    3:09 Low-dose CT screening uptake in Canada
    4:45 Evolution of adjuvant, neoadjuvant therapies
    7:10 Reviewing CheckMate 816
    10:56 Reviewing KEYNOTE-671
    12:58 The impact of neoadjuvants on operability
    16:15 Treatment-specific biomarkers for lung cancer
    21:13 The short-term future of lung cancer therapy
    24:31 Outro

    Precision medicine–delivering the right drug at the right time to the right patient–is the direction in which lung cancer treatment is heading. In this episode, we talk about an exciting, emerging drug class with one of the most prominent investigators involved with its development, Dr. Jonathan Spicer at McGill University’s Thoracic Oncology Network. 

    It provides a deep dive into neoadjuvant therapy for patients who have operable lung cancer, offering insight into what is currently known about response and failure rates.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show more Show less
activate_primeday_promo_in_buybox_DT
Show more Show less

What listeners say about The Promise of Lung Cancer Precision Medicine with Dr. Jonathan Spicer

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available